Mylan Takes Actelion Drug IP Fight To Fed. Circ.
By Jasmin Boyce ( June 7, 2022, 7:26 PM EDT) -- Mylan Pharmaceuticals Inc. said Tuesday it's appealing to the Federal Circuit a West Virginia district judge's claim construction order after being blocked from selling a generic version of rival Actelion Pharmaceuticals Ltd.'s blood pressure treatment Veletri....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.